- Member of our IPO team that raised $394 million in two S-1 filings in 2019 and raised an additional $373M in the first half of 2020. - Built a team of seven to manage all aspects of the accounting function including actively managing multiple on-going clinical trials.- Responsible for managing all accounting and financial reporting functions for the month end close process. - Implemented new accounting system prior to our April 2019 IPO.- Team leader for the Implementation of Sarbanes-Oxley requirements to ensure the Company is SOX 404b compliant for the fiscal year 2020. - Manage the preparation of SEC filings including MD&A for our Quarterly Form 10-Q and annual Form 10-K.- Tax compliance and coordination with our outside service providers

Reduction in force in July 2018.

• Prepared all footnote and MD&A supporting schedules for the Form 10-Q and 10-K.• Responsible for the tie out of all financial data within the Form 10-Q and 10-K prior to the filing with the SEC. • Worked directly with our independent accounting firm to ensure the Company has complied with SEC rules and regulations prior to the filing of our financial statements with the SEC. • Prepared all accounting memos detailing the accounting issue, applicable accounting literature and how the Company properly accounted for such issues under U.S. GAAP. • Responsible for coordinating and reviewing all month-end journal entries and general ledger reconciliations, prepared by the Accounts Payable and Payroll Supervisor.• Complete and provide quarterly income statement and balance sheet fluctuations to our independent auditors / reviewers.• Complete the monthly budget versus actual analyses and provide detailed explanations for significant or unusual variances.

• Managed all aspects of the financial statement audit process including planning, preparing detailed budgets, supervising staff, client service and reporting in a “Big 4” environment.• Performed extensive review of balance sheet and income statement accounts through analytical review procedures, ratio analysis and substantive procedures.• Prepared and analyzed financial statements, including footnote disclosures in compliance with GAAP. • Scheduled, supervised, motivated and evaluated approximately 5 professional staff per engagement, including performing written and oral evaluations.• Developed internal control recommendations for private and public companies to increase their administrative and operational efficiency.• Established positive client working relationships. Client experience includes Scripps Health, Mad Catz International, Inc and Color Spot Nurseries. • Researched and analyzed FASBs (SFAS: 13, 48, 123R, 133, 141, 142 and 144) and EITFs and applied the literature to specific issues related to the financial statements under audit. • Managed the review process and tie out of the MD&A and financial statements within the quarterly 10-Q and annual 10-K filings, providing revisions directly to clients to conform all filings to SEC rules and regulations.

• Performed financial statement audits.• Proposed adjusting journal entries as needed during the course of the audit.• Preparation of financial statements.• Application of analytical procedures to finalized financial statements.

• Audited client’s A/R, inventory and cash accounts and prepared a report of my findings.• Reviewed the most recent purchasing invoices to provide evidence that the inventory collateral was properly valued.